Jorge Capapey

VP, Global Rare Disease Lead at Alnylam Pharmaceuticals

Role
VP, Global Rare Disease Lead at Alnylam Pharmaceuticals
Location
Cambridge, MA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Jorge Capapey

A board-certified physician with over 18 years of broad experience in the pharmaceutical industry covering from lifecycle management to medical affairs to commercial functions - including country, regional and global leadership positions. Passionate for rare diseases, I have contributed to bring to patients in need the breakthrough treatments Tracleer (for Pulmonary Hypertension), OFEV (for Interstitial Lung Disease), Myalepta (for Lipodistrophy). and we are doing it again at Alnylam! Unleashing the potential of RNA interference science to make first-in-class RNAi medicines to treat patients with ATTR Amyloidosis, Acute Hepatic Porphyria and Primary Hyperoxaluria.

Experience

  1. VP, Global Rare Disease Lead

    Alnylam Pharmaceuticals

    Apr 2022 — Present · Cambridge, MA, US

    Leading Alnylam\'s efforts in developing and commercializing treatments for rare and ultra-rare conditions. From this newly created role I support teams from the most diverse functions, from early development to commercial, to achieve our common goal of improving patients\' lives. Bringing together lifecycle management and commercial leadership roles to put the patients at the center of the RNAi revolution.

Education

  • Universitat de Barcelona

    Doctor of Medicine (MD), Licenciado en Medicina y Cirugía, MD

    1992 — 1999

  • Talento Farmacéutico y Sanitario. Business School

    Negociacion en el entorno sanitario, Negotiation with healthcare agencies

    2019 — 2019

  • Universitat de Barcelona

    MIR, Psychiatry, Psychiatry Residency Program

    2000 — 2004

  • ESADE Business School

    Masters; MBA, Business Administration

    2006 — 2008

  • American Managment Association

    Team Leadership Diplomma

    2011 — 2011

  • IMD (International Institute for Management Development) - Business Programs

    High Performance Leadership, Business Administration and Management, General

    2012 — 2012

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Jorge Capapey — VP, Global Rare Disease Lead at Alnylam Pharmaceuticals in Cambridge, MA, US | Unifers